These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. Bavry AA; Bhatt DL Lancet; 2008 Jun; 371(9630):2134-43. PubMed ID: 18572082 [TBL] [Abstract][Full Text] [Related]
11. Drug-eluting stents: issues of late stent thrombosis. Lemesle G; Maluenda G; Collins SD; Waksman R Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052 [TBL] [Abstract][Full Text] [Related]
12. Which patients receiving warfarin can be treated safely with a drug-eluting stent? Ryding AD; Banning AP Heart; 2008 Mar; 94(3):275-7. PubMed ID: 18276815 [No Abstract] [Full Text] [Related]
13. In-stent restenosis. Kim MS; Dean LS Cardiovasc Ther; 2011 Jun; 29(3):190-8. PubMed ID: 20406239 [TBL] [Abstract][Full Text] [Related]
14. Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications. ten Berg JM; Hutten BA; Kelder JC; Verheugt FW; Plokker HW Circulation; 2001 Apr; 103(16):2042-7. PubMed ID: 11319192 [TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stents - what should be improved? Steffel J; Eberli FR; Lüscher TF; Tanner FC Ann Med; 2008; 40(4):242-52. PubMed ID: 18428018 [TBL] [Abstract][Full Text] [Related]
16. Dual antiplatelet therapy in acute coronary syndrome after stent implantation: How short is short and how long is long? Tsioufis C Hellenic J Cardiol; 2018; 59(6):376-377. PubMed ID: 30682418 [No Abstract] [Full Text] [Related]
17. [Advances in adjunctive pharmacological therapy for percutaneous coronary interventions]. Benito B; Masotti M; Betriu A Rev Esp Cardiol; 2005 Jun; 58(6):729-43. PubMed ID: 15970124 [TBL] [Abstract][Full Text] [Related]
18. [Intracoronary gamma brachytherapy significantly lowers the restenosis rate after PTCA and stent implantation]. Strnad V Strahlenther Onkol; 2002 Jan; 178(1):51. PubMed ID: 11977393 [No Abstract] [Full Text] [Related]
19. Drug-eluting stents to prevent stent thrombosis and restenosis. Im E; Hong MK Expert Rev Cardiovasc Ther; 2016; 14(1):87-104. PubMed ID: 26567863 [TBL] [Abstract][Full Text] [Related]
20. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis. El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]